Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Propanc Biopharma Inc (PPCB)

Propanc Biopharma Inc (PPCB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 512
  • Shares Outstanding, K 1,312
  • Annual Sales, $ 0 K
  • Annual Income, $ -5,760 K
  • 60-Month Beta 4.50
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -40.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/15/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3000 +20.00%
on 11/11/19
0.9500 -62.11%
on 10/22/19
-0.4850 (-57.40%)
since 10/14/19
3-Month
0.3000 +20.00%
on 11/11/19
1.5900 -77.36%
on 08/15/19
-1.0900 (-75.17%)
since 08/14/19
52-Week
0.0600 +500.00%
on 06/24/19
28.5000 -98.74%
on 12/19/18
-15.1400 (-97.68%)
since 11/14/18

Most Recent Stories

More News
Propanc Biopharma Provides Shareholder Update and Forecast for 2020

Propanc Biopharma, Inc. (OTC: PPCB) ("Propanc" or the "Company"), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and metastatic cancer, announced today...

PPCB : 0.3600 (-7.69%)
Propanc Biopharma Illustrates Novel Mode of Action of PRP, Suppressing EMT Pathways and Metastasis in Cancer Patients

Propanc Biopharma, Inc. (OTC: PPCB) ("Propanc" or the "Company"), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and metastatic cancer, announced today...

PPCB : 0.3600 (-7.69%)
Propanc Biopharma Receives Granted US Patent Covering Additional Composition Claims for PRP

Propanc Biopharma, Inc. (OTC: PPCB) ("Propanc"), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and metastatic cancer, announced today that it has received...

PPCB : 0.3600 (-7.69%)
CORRECTING and REPLACING Propanc Biopharma Publishes Key Data in Peer Reviewed Journal Confirming Anti-Cancer Stem Cell Effects of Proenzymes

First paragraph, first sentence of release should read: Propanc Biopharma, Inc. (OTC: PPCB) ("Propanc"), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring...

PPCBD : 1.9900 (-9.55%)
PPCB : 0.3600 (-7.69%)
Propanc Biopharma Publishes Key Data in Peer Reviewed Journal Confirming Anti-Cancer Stem Cell Effects of Proenzymes

Propanc Biopharma, Inc. (OTC: PPCBD) ("Propanc"), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and metastatic cancer, announced today that the company's...

PPCB : 0.3600 (-7.69%)
PPCBD : 1.9900 (-9.55%)
Propanc Biopharma Completes Development of Bio-analytical Assay Method to Quantify PRP's Active Ingredients in Preparation for First-In-Human Study

Propanc Biopharma, Inc. (OTC: PPCB) ("Propanc"), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and metastatic cancer, announced today it has developed...

PPCB : 0.3600 (-7.69%)
Propanc Biopharma Provides Update on Preparation of PRP for Clinical Trial Application Submission and Recently Completed Reverse Stock Split

Propanc Biopharma, Inc. (OTC: PPCBD) ("Propanc"), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and metastatic cancer, announced today an update on...

PPCB : 0.3600 (-7.69%)
PPCBD : 1.9900 (-9.55%)
Propanc Biopharma's Intellectual Property Portfolio Undergoes Rapid Growth

Propanc Biopharma, Inc. (OTC: PPCBD) ("Propanc"), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and metastatic cancer, announced today that Propanc's...

PPCB : 0.3600 (-7.69%)
PPCBD : 1.9900 (-9.55%)
Propanc Biopharma Appoints Carlo Campiciano as Chief Financial Officer

Propanc Biopharma, Inc. (OTC: PPCB) ("Propanc", the "Company", "we", "our", or "us"), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and metastatic cancer,...

PPCB : 0.3600 (-7.69%)
Propanc Biopharma Appoints Dr. Ralf Brandt to its Scientific Advisory Board

Propanc Biopharma, Inc. (OTCQB: PPCB) ("Propanc"), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and metastatic cancer, announced...

CGIX : 2.75 (-5.82%)
PPCB : 0.3600 (-7.69%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade PPCB with:

Key Turning Points

2nd Resistance Point 0.4600
1st Resistance Point 0.4100
Last Price 0.3600
1st Support Level 0.3100
2nd Support Level 0.2600

See More

52-Week High 28.5000
Fibonacci 61.8% 17.6359
Fibonacci 50% 14.2800
Fibonacci 38.2% 10.9241
Last Price 0.3600
52-Week Low 0.0600

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar